Literature DB >> 14824275

The labile factor of prothrombin conversion: its consumption under normal and pathological conditions affecting blood coagulation.

B ALEXANDER, R GOLDSTEIN, G LANDWEHR.   

Abstract

Entities:  

Keywords:  PROTHROMBIN

Mesh：

Substances：

Year:  1951        PMID： 14824275      PMCID： PMC436254          DOI： 10.1172/JCI102439

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  9 in total

1.  The fifth coagulation factor (;Factor V'). Preparation and properties.

Authors:  P A Owren
Journal:  Biochem J       Date:  1948       Impact factor: 3.857

2.  HUMAN PROTHROMBIN: QUANTITATIVE STUDIES ON THE PLASMA LABILE FACTOR AND THE RESTORATIVE EFFECTS OF NORMAL, HYPOFI-BRINOGENEMIC, AND HEMOPHILIC PLASMA ON THE PROTHROMBIN OF STORED PLASMA.

Authors:  B Alexander; A De Vries; E Addelson
Journal:  J Clin Invest       Date:  1949-01       Impact factor: 14.808

3.  THROMBIN FORMATION. I. THE ROLE OF CALCIUM, SERUM AC-GLOBULIN AND TISSUE THROMBOPLASTIN.

Authors:  J H Lewis; J H Ferguson
Journal:  J Clin Invest       Date:  1948-11       Impact factor: 14.808

4.  The prothrombin consumption test; its clinical and theoretic implications.

Authors:  A J QUICK; J E FAVRE-GILLY
Journal:  Blood       Date:  1949-12       Impact factor: 22.113

5.  Thrombasthenia and thrombocytopenic purpura; report of case demonstrating qualitative and quantitative inadequacy of platelets.

Authors:  B ALEXANDER; G LANDWEHR
Journal:  N Engl J Med       Date:  1949-12-15       Impact factor: 91.245

6.  Prothrombin, thromboplastin, Ac-globulin and platelet accelerator: quantitative interrelationships.

Authors:  R I McCLAUGHRY; W H SEEGERS
Journal:  Blood       Date:  1950-04       Impact factor: 22.113

7.  The prothrombin conversion accelerator of serum (SPCA): its partial purification and its properties compared with serum AC-globulin.

Authors:  B ALEXANDER; R GOLDSTEIN; G LANDWEHR
Journal:  J Clin Invest       Date:  1950-07       Impact factor: 14.808

8.  Nature of action of the labile factor in formation of thrombin.

Authors:  A J QUICK; M STEFANINI
Journal:  Am J Physiol       Date:  1950-03

9.  Prothrombin consumption, serum prothrombic activity and prothrombin conversion accelerator in hemophilia and thrombocytopenia.

Authors:  B ALEXANDER; G LANDWEHR
Journal:  J Clin Invest       Date:  1949-11       Impact factor: 14.808
  9 in total
  6 in total

1.  Studies in intravascular coagulation. III. The pathogenesis of serum-induced venous thrombosis.

Authors:  S WESSLER
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  The action of heparin in the prevention of prothrombin conversion.

Authors:  A S DOUGLAS
Journal:  J Clin Invest       Date:  1956-05       Impact factor: 14.808

3.  Basic mechanisms of hemostasis.

Authors:  M STEFANINI
Journal:  Bull N Y Acad Med       Date:  1954-04

4.  The initial stages of blood coagulation.

Authors:  R BIGGS; A S DOUGLAS; R G MACFARLANE
Journal:  J Physiol       Date:  1953-12-29       Impact factor: 5.182

5.  Physiopathological classification of the haemorrhagic diseases.

Authors:  P DE NICOLA
Journal:  Can Med Assoc J       Date:  1952-12       Impact factor: 8.262

6.  Synthesis of clotting factors by the isolated perfused rat liver.

Authors:  J P Olson; L L Miller; S B Troup
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.